Skip to Content

Columbia Capital Allocation Cnsrv A ABDAX

Analyst rating as of
Premium

Morningstar’s Analysis

Will ABDAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Recent portfolio changes benefit this series.

Summary

| |

The Columbia Capital Allocation target-risk series made positive changes in 2020 by consolidating its underlying fund lineup, but its management team continues to implement a fairly standard approach. All share classes earn a Morningstar Analyst Rating of Neutral.

Unlock our full analysis with Morningstar Premium